NAGE
Niagen Bioscience, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$291.50M
P/E Ratio
17.43
EPS
$0.21
Beta
2.17
52W High
$14.69
52W Low
$3.57
50-Day MA
$4.47
200-Day MA
$6.55
Dividend Yield
—
Profit Margin
14.30%
Forward P/E
14.12
PEG Ratio
—
About Niagen Bioscience, Inc.
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | $130.42M |
| Gross Profit (TTM) | $83.83M |
| EBITDA | $11.98M |
| Operating Margin | 5.01% |
| Return on Equity | 27.10% |
| Return on Assets | 7.09% |
| Revenue/Share (TTM) | $1.64 |
| Book Value | $1.03 |
| Price-to-Book | 3.55 |
| Price-to-Sales (TTM) | 2.23 |
| EV/Revenue | 1.752 |
| EV/EBITDA | 18.07 |
| Quarterly Earnings Growth (YoY) | 16.70% |
| Quarterly Revenue Growth (YoY) | 3.30% |
| Shares Outstanding | $79.64M |
| Float | $59.60M |
| % Insiders | 29.25% |
| % Institutions | 47.48% |
Historical Volatility
HV 10-Day
40.70%
HV 20-Day
68.76%
HV 30-Day
65.59%
HV 60-Day
55.15%
HV Rank
76.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($12.60 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026